Showing results (1931-1940 of 10,561) with videos related to

Sort By:
Pageof 1,057
Thrombosis Research|July 12, 2023
What do we know about platelets in myocardial ischemia-reperfusion injury and why is it important?Lun Wang, Yifan Liu, Ran Tian, et al.
Thrombosis Research|July 8, 2023
Force-induced biphasic regulation of VWF cleavage by ADAMTS13Jiangguo Lin, Xiaoru Ding, Pu Yang, et al.
Thrombosis Research|June 25, 2023
Sources of variability in the human platelet transcriptomeFlorian Thibord, Andrew D Johnson
Thrombosis Research|June 8, 2023
The international normalised ratio to monitor coagulation factor production during normothermic machine perfusion of human donor liversBente P van den Boom, Silke B Bodewes, Bianca Lascaris, et al.
Thrombosis Research|February 2, 2019
Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparinDamian Ratano, Lorenzo Alberio, Frederik Delodder, et al.
Thrombosis Research|January 1, 2019
Enhanced thrombin generation in patients with arterial hypertensionAdi Elias, Wasseem Rock, Ahmad Odetalla, et al.
Thrombosis Research|January 1, 2019
Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: A retrospective cohort studyAna Acuna-Villaorduna, Vivy Tran, Jesus D Gonzalez-Lugo, et al.
Thrombosis Research|February 15, 1987
V1a-vasopressin specific receptors on human platelets: potentiation by ADP and epinephrine and evidence for homologous down-regulationJ M Launay, D Vittet, M Vidaud, et al.
Thrombosis Research|February 8, 2019
Thromboembolic disease in palliative and end-of-life care: A narrative reviewNicolas Chin-Yee, Peter Tanuseputro, Marc Carrier, et al.
Thrombosis Research|September 26, 2020
Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolismThomas Delate, Malti Charlu, Shiyun Zhu, et al.
Pageof 1,057